Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$260M |
| 2 |
Y
Alleghany Corporation
Y
|
+$139M |
| 3 |
FBC
Flagstar Bancorp, Inc. New
FBC
|
+$137M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
+$121M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$86.4M |
Sector Composition
| 1 | Financials | 15.11% |
| 2 | Technology | 12.49% |
| 3 | Industrials | 10.78% |
| 4 | Healthcare | 9.96% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALYA
2801
DELISTED
Alithya Group inc. Class A Subordinate Voting Shares
ALYA
| $1.5K | ﹤0.01% |
1,013,790
| – | – |
|
2802
BioXcel Therapeutics
BTAI
$54.3M
| $1.49K | ﹤0.01% |
4,333
-314
| -7% | -$108 |
|
2803
Blue Bird Corp
BLBD
$1.85B
| $1.49K | ﹤0.01% |
138,876
-118,042
| -46% | -$1.27K |
|
2804
Airgain
AIRG
$49.4M
| $1.49K | ﹤0.01% |
228,475
+13,918
| +6% | +$91 |
|
2805
Eagle Bancorp Montana
EBMT
$140M
| $1.49K | ﹤0.01% |
91,986
-116
| -0.1% | -$2 |
|
2806
Purple Innovation
PRPL
$116M
| $1.49K | ﹤0.01% |
310,481
+139,989
| +82% | +$670 |
|
2807
Inovio Pharmaceuticals
INO
$141M
| $1.47K | ﹤0.01% |
78,690
+63,810
| +429% | +$1.19K |
|
|
SCWX
2808
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.47K | ﹤0.01% |
229,812
-16,292
| -7% | -$104 |
|
|
PSTX
2809
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.47K | ﹤0.01% |
276,419
+155,476
| +129% | +$824 |
|
2810
Recursion Pharmaceuticals
RXRX
$2.12B
| $1.46K | ﹤0.01% |
+189,928
| New | +$1.46K |
|
2811
OptimizeRx
OPRX
$350M
| $1.46K | ﹤0.01% |
86,991
+21,500
| +33% | +$361 |
|
2812
Lifeway Foods
LWAY
$499M
| $1.46K | ﹤0.01% |
262,878
-604
| -0.2% | -$3 |
|
2813
Sensus Healthcare
SRTS
$53.3M
| $1.45K | ﹤0.01% |
195,245
| – | – |
|
2814
Lazydays
GORV
$8.89M
| $1.44K | ﹤0.01% |
4,024
-492
| -11% | -$176 |
|
2815
Optical Cable Corp
OCC
$70.4M
| $1.44K | ﹤0.01% |
346,327
+69
| +0% | – |
|
2816
MeridianLink
MLNK
$1.47B
| $1.44K | ﹤0.01% |
104,743
+9,941
| +10% | +$136 |
|
2817
JFrog
FROG
$5.82B
| $1.42K | ﹤0.01% |
+66,590
| New | +$1.42K |
|
2818
Transact Technologies
TACT
$46.6M
| $1.42K | ﹤0.01% |
227,915
+4
| +0% | – |
|
2819
Organogenesis Holdings
ORGO
$639M
| $1.41K | ﹤0.01% |
525,217
-210,230
| -29% | -$566 |
|
2820
IBEX
IBEX
$407M
| $1.41K | ﹤0.01% |
56,762
+42,034
| +285% | +$1.05K |
|
2821
Cumberland Pharmaceuticals
CPIX
$51.3M
| $1.4K | ﹤0.01% |
623,871
+4
| +0% | – |
|
2822
Urban One Class A
UONE
$64M
| $1.4K | ﹤0.01% |
306,841
+6,693
| +2% | +$30 |
|
|
AGS
2823
DELISTED
PlayAGS
AGS
| $1.39K | ﹤0.01% |
272,812
+18,214
| +7% | +$93 |
|
2824
Gold Resource Corp
GORO
$114M
| $1.39K | ﹤0.01% |
908,039
-122,957
| -12% | -$188 |
|
|
PHLT
2825
Performant Healthcare, Inc. Common Stock
PHLT
$607M
| $1.38K | ﹤0.01% |
382,644
+43,307
| +13% | +$156 |
|